News

Call for proposals for a new recognition prize: EU Award for Gender Equality Champions

Published on | 2 years ago

Programmes Enhancing EU R&I Horizon Europe

A call for proposals is open for the new recognition prize EU Award for Gender Equality Champions. The prize is meant to:

There are three prize categories:

  • Sustainable Gender Equality Champions
  • Newcomer Gender Equality Champions
  • Inclusive Gender Equality Champions

Candidates can only apply to one of these three categories. Applicants can be a university, higher education institution, or research performing organisation (public or private) located in an EU Member State or a country associated to Horizon Europe.

Deadline for applications is 13 October 2022 at 17.00 (CET). Winners receive a prize of 100.000 euro. In the Sustainable Gender Equality Champions category two winners will be awarded a prize. Winners will be announced before the end of 2022 (HE WIDERA work programme 2021-2022, p.154-156).

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1646 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.